pe
pep-05328 v1 CC-BY-SA-4.0

Beta-defensin 25 anticancer peptide

A peptide studied in the lab for its ability to fight cancer cells; experimental, not yet an approved drug.

statuscomputed targetANTICANCER length49 aa refs3
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 2 contributors
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.700
avg pLDDT77.6
ranking score0.761
STRUCTURE · PEP-05328 × ANTICANCER
ranking0.761
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence49 aa
15101520253035404549
EFKRCWN GQGACRT FCTRQET FMHLCPD ASLCCLS YSFKPSR PSRVGDV
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.76082444190979 boltz-2
3-letter notation
Glu-Phe-Lys-Arg-Cys-Trp-Asn-Gly-Gln-Gly-Ala-Cys-Arg-Thr-Phe-Cys-Thr-Arg-Gln-Glu-Thr-Phe-Met-His-Leu-Cys-Pro-Asp-Ala-Ser-Leu-Cys-Cys-Leu-Ser-Tyr-Ser-Phe-Lys-Pro-Ser-Arg-Pro-Ser-Arg-Val-Gly-Asp-Val
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). Beta-defensin 25 anticancer peptide (pep-05328, v1). PeptideModel. https://peptidemodel.com/card/pep-05328
@peptide{pep05328,
  sequence = {EFKRCWNGQGACRTFCTRQETFMHLCPDASLCCLSYSFKPSRPSRVGDV},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {computed}
}
related peptides 5 by signal overlap
references 3 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use